Investor Presentaiton

Eurofins has built a valuable portfolio of Routine and Specialized Clinical Diagnostics Laboratories in France * eurofins Eurofins Clinical Diagnostics operations in France amount to ca. €400m of revenues. These €400m revenues were acquired over the last 4 years for ca. €600-700m, representing an average EV / revenue acquisition multiple of 1.5x to 1.75x. Over the last three years, Clinical Diagnostics companies in France have, on average, been acquired at over 3x target revenues. Comparable M&A transactions in Clinical Diagnostics in France: Date Target Acquirer EV in €m EV / target revenues March 2018 BIO7 Cerba 500 4.5x January 2017 Cerba PSP, Partners Group 1,800 2.9x 63 63

View entire presentation